Malnutrition in CF now includes an increasing prevalence of overweight and obesity, particularly in those receiving CF transmembrane conductance regulator (CFTR) modulator therapy (CFTRm). Here, CFTR is linked to obesity due to melanocortin 4 receptor deficiency.